New hope for tough cancers: pfizer tests experimental drug
NCT ID NCT07519655
First seen Apr 15, 2026 · Last updated May 04, 2026 · Updated 2 times
Summary
This early-stage study tests a new medicine, PF-08046033, in adults with advanced lung cancer, esophageal cancer, or melanoma that has spread or can't be removed. The main goals are to check safety, find the right dose, and see if it helps control the cancer. Participants receive the drug in cycles and are closely monitored for side effects and tumor response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Oncologico Dr. Isaac Gonzalez-Martinez
RECRUITINGRio Piedras, 00935, Puerto Rico
-
Pan American Center for Oncology Trials, LLC
RECRUITINGRio Piedras, 00935, Puerto Rico
-
Presbyterian/St Lukes Medical Center
RECRUITINGDenver, Colorado, 80218, United States
-
SCRI Oncology Partners
NOT_YET_RECRUITINGNashville, Tennessee, 37203, United States
-
Sarah Cannon Research Institute at HealthONE
RECRUITINGDenver, Colorado, 80218, United States
-
Sarah Cannon Research Institute- Pharmacy
NOT_YET_RECRUITINGNashville, Tennessee, 37203, United States
Conditions
Explore the condition pages connected to this study.